湖北大翔药业有限公司招聘

Introduction of Hubei Daxiang Pharmaceutical Co., Ltd.

Hubei Daxiang Pharmaceutical Co., Ltd. (hereinafter referred to as "Daxiang"), headquartered in Wuhan, Hubei, is a pharmaceutical GSP wholesale enterprise. The company also operates another GSP wholesale entity for medical devices, Hubei Beatrixmer Medical Technology Co., Ltd. (hereinafter referred to as "Beatrixmer"). Its business scope includes provincial agency and national platform construction for prescription drugs, retail, and medical aesthetics. Through strategic partnerships with various commercial channels, the company provides specialized academic promotion and marketing planning services across different regions. After rapid growth over the years, it has become a large-scale pharmaceutical company with assets exceeding one billion yuan and over a hundred employees. The company's three main business segments are: Prescription Drug Division, Retail Division, and Medical Aesthetics Division.

1. Prescription Drug Division (RX): Collaborating with well-known pharmaceutical companies such as Xi'an Happiness, Yunnan Sailing, Chengdu Betta, Yunnan Plant, Hefei YiFan, Guizhou Weikang Zifan, Shenzhen Buddha, and Sandoz (China), it forms a professional promotion team. This team covers over 2,000 hospitals, including tertiary hospitals and grassroots hospitals in Hubei and Henan provinces, in areas like oncology, liver disease, orthopedics, gynecology, and pediatrics. In commercial distribution, the company has deep strategic partnerships with major commercial systems such as Sinopharm, China Resources, Jiuzhou Tong, Haiwang, Chongqing Medicine, and Nanfang Medicine. It collaborates extensively with over 300 pharmaceutical distribution enterprises across cities in two provinces, covering target hospitals in Hubei and Henan. The company offers professional solutions in market access, development capability, academic capability, and sales capability.

2. Retail Division (MR): Established in 2017, the company formed a retail marketing team covering the entire province of Hubei, primarily focusing on direct operations. It successfully developed a new retail model for prescription drugs combined with high-value single products, forming strategic partnerships with many well-known chain enterprises in Hubei, such as Hubei Laobaigan Chain, Hubei Yifeng Chain, and Hubei Tianji Chain. In the future, the Retail Division plans to expand its business footprint and build a health service system in Central China.

3. Medical Aesthetics Division (EM): Primarily engaged in medical beauty services. Over the past two years, the company has represented excellent brands such as "Young Skin," "Jelly Needles," Galderma series, Hyaluron series, Korea Letybo Botulinum Toxin, and Austria Princess Hyaluronic Acid in major medical beauty institutions in Hubei and Henan. These brands have held thousands of academic meetings, igniting marketing storms in the medical beauty industry in both provinces.

Daxiang Pharmaceutical will achieve its mission of "serving the industry through products and creating the future through service," adhering to the business philosophy of "caring for human health." It aims to promote the thriving development of the healthcare industry and contribute to the great rejuvenation of the Chinese nation.